Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
AstraZeneca's £450m UK investment deal axed as it 'didn't add up for taxpayer'
AstraZeneca has cancelled a multi-million pound investment in a vaccine plant in Merseyside because the government failed to match the previous government's offer of support
UK hits back at AstraZeneca over collapse of investment deal
Britain on Monday hit back at AstraZeneca over the collapse of a 450 million pound ($558.5 million) investment, saying the drugmaker had scaled back the research and development portion of its plans,
Blow for Reeves as AstraZeneca ditches £450m investment
AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Merseyside, blaming a reduction in government support. The pharmaceutical giant announced its decision just two days after Chancellor Rachel Reeves set out Labour's plan to go "further and faster" to boost economic growth.
AstraZeneca abandons £450m vaccine factory in blow to Reeves
AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start economic growth...
AstraZeneca ditches UK investment over cut in state support
AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England, citing a cut in British government support.
AstraZeneca cancels £450m investment in UK after dispute over Government support
The pharmaceutical giant claimed the Labour Government failed to match its predecessor’s offer of help for the Merseyside investment.
Fresh blow for Rachel Reeves as AstraZeneca scraps £450m investment in UK vaccine plant
Fresh blow for Rachel Reeves as AstraZeneca scraps £450m investment in UK vaccine plant - The pharmaceutical giant claimed the Labour Government failed to match its predecessor’s offer
20h
on MSN
AstraZeneca offered 'significant' sum, says minister
The firm scrapped its £450m investment despite the government's offer of support, the government says.
30m
AstraZeneca Sales, Core EPS Seen Rising -- Earnings Preview
CORE EARNINGS PER SHARE: Core earnings per share are expected to rise to $2.07 from $1.45 the year prior, according to the same consensus. AstraZeneca's stock is up 7.9% since the start of 2024.
1h
AstraZeneca reaffirms commitment to cancer care on World Cancer Day 2025
In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative ...
1d
AstraZeneca Stock Rally Will be Tested by Answers on China Probe
A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...
2h
U.K. defends negotiations with AstraZeneca, BBC News reports
The U.K. government is defending its negotiations with AstraZeneca (AZN), after the pharmaceutical company dropped a planned $558M investment ...
Medscape
1d
AstraZeneca Sues Generic Drugmakers, Claims Cancer Drug Patent Violations
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
The Star
4h
AstraZeneca to introduce advanced lung cancer testing in Kenya
Biopharmaceutical giant AstraZeneca has announced it is introducing advanced diagnostic testing for lung cancer in Kenya and ...
Pharmaceutical Technology
8h
AstraZeneca lung cancer therapy Imfinzi recommended for EU approval
EMA's CHMP has recommended AstraZeneca's Imfinzi for approval in the EU as a single agent for limited-stage small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
United States
vaccine
World Cancer Day
Enhertu
Daiichi Sankyo
Feedback